GlassScriptPhysician profile
Benjamin Portal
NPI 1235585449
$701.17
in general payments reported to CMS, 2019-2025
13 companies · $56.47 in 2025
The $56.47 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $276 · 2022: $264 · 2023: $105 · 2025: $56.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $161.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $154.27 | 2022-2023 | |
| Boston Scientific Corporation | $102.78 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $84.30 | 2022 | |
| Collegium Pharmaceutical, INC. | $65.14 | 2021-2022 | |
| Redhill Biopharma INC. | $59.35 | 2021-2022 | |
| Linvatec Corporation | $56.47 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $54.10 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $40.62 | 2022 | |
| Forte Bio-Pharma LLC | $29.56 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $17.43 | 2021 | |
| Allergan, INC. | $14.84 | 2022 | |
| Currax Pharmaceuticals LLC | $11.27 | 2021 | |
| Eisai INC. | $11.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Portal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.